153 related articles for article (PubMed ID: 23745707)
1. The RAMP-interacting Family B G Protein-Coupled Receptors and Their Specific Bioactive Peptides.
Kuwasako K
Curr Protein Pept Sci; 2013 Jun; ():. PubMed ID: 23745707
[No Abstract] [Full Text] [Related]
2. The RAMP-interacting Family B G protein-coupled receptors and their specific bioactive peptides.
Kuwasako K
Curr Protein Pept Sci; 2013 Jun; 14(4):243-5. PubMed ID: 23808677
[No Abstract] [Full Text] [Related]
3. Molecular basis of association of receptor activity-modifying protein 3 with the family B G protein-coupled secretin receptor.
Harikumar KG; Simms J; Christopoulos G; Sexton PM; Miller LJ
Biochemistry; 2009 Dec; 48(49):11773-85. PubMed ID: 19886671
[TBL] [Abstract][Full Text] [Related]
4. RAMPs as allosteric modulators of the calcitonin and calcitonin-like class B G protein-coupled receptors.
Pioszak AA; Hay DL
Adv Pharmacol; 2020; 88():115-141. PubMed ID: 32416865
[TBL] [Abstract][Full Text] [Related]
5. Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins.
Kotliar IB; Lorenzen E; Schwenk JM; Hay DL; Sakmar TP
Pharmacol Rev; 2023 Jan; 75(1):1-34. PubMed ID: 36757898
[TBL] [Abstract][Full Text] [Related]
6. Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product.
Christopoulos G; Perry KJ; Morfis M; Tilakaratne N; Gao Y; Fraser NJ; Main MJ; Foord SM; Sexton PM
Mol Pharmacol; 1999 Jul; 56(1):235-42. PubMed ID: 10385705
[TBL] [Abstract][Full Text] [Related]
7. An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacology.
J Gingell J; Simms J; Barwell J; Poyner DR; Watkins HA; Pioszak AA; Sexton PM; Hay DL
Cell Discov; 2016; 2():16012. PubMed ID: 27462459
[TBL] [Abstract][Full Text] [Related]
8. Complexing receptor pharmacology: modulation of family B G protein-coupled receptor function by RAMPs.
Sexton PM; Morfis M; Tilakaratne N; Hay DL; Udawela M; Christopoulos G; Christopoulos A
Ann N Y Acad Sci; 2006 Jul; 1070():90-104. PubMed ID: 16888151
[TBL] [Abstract][Full Text] [Related]
9. Functional interaction of G protein-coupled receptors of the adrenomedullin peptide family with accessory receptor-activity-modifying proteins (RAMP).
Born W; Muff R; Fischer JA
Microsc Res Tech; 2002 Apr; 57(1):14-22. PubMed ID: 11921352
[TBL] [Abstract][Full Text] [Related]
10. Sequence analysis of the Receptor Activity-Modifying Proteins family, new putative peptides and structural conformation inference.
Benítez-Páez A
In Silico Biol; 2006; 6(6):467-83. PubMed ID: 17518758
[TBL] [Abstract][Full Text] [Related]
11. Evidence for Conservation of the Calcitonin Superfamily and Activity-regulating Mechanisms in the Basal Chordate Branchiostoma floridae: INSIGHTS INTO THE MOLECULAR AND FUNCTIONAL EVOLUTION IN CHORDATES.
Sekiguchi T; Kuwasako K; Ogasawara M; Takahashi H; Matsubara S; Osugi T; Muramatsu I; Sasayama Y; Suzuki N; Satake H
J Biol Chem; 2016 Jan; 291(5):2345-56. PubMed ID: 26644465
[TBL] [Abstract][Full Text] [Related]
12. Multiplexed analysis of the secretin-like GPCR-RAMP interactome.
Lorenzen E; Dodig-Crnković T; Kotliar IB; Pin E; Ceraudo E; Vaughan RD; Uhlèn M; Huber T; Schwenk JM; Sakmar TP
Sci Adv; 2019 Sep; 5(9):eaaw2778. PubMed ID: 31555726
[TBL] [Abstract][Full Text] [Related]
13. The expanding repertoire of receptor activity modifying protein (RAMP) function.
Klein KR; Matson BC; Caron KM
Crit Rev Biochem Mol Biol; 2016; 51(1):65-71. PubMed ID: 26740457
[TBL] [Abstract][Full Text] [Related]
14. Dawn of a New RAMPage.
Serafin DS; Harris NR; Nielsen NR; Mackie DI; Caron KM
Trends Pharmacol Sci; 2020 Apr; 41(4):249-265. PubMed ID: 32115276
[TBL] [Abstract][Full Text] [Related]
15. Modulating effects of RAMPs on signaling profiles of the glucagon receptor family.
Shao L; Chen Y; Zhang S; Zhang Z; Cao Y; Yang D; Wang MW
Acta Pharm Sin B; 2022 Feb; 12(2):637-650. PubMed ID: 35256936
[TBL] [Abstract][Full Text] [Related]
16. Expanding the GPCR-RAMP interactome.
Kotliar IB; Bendes A; Dahl L; Chen Y; Saarinen M; Ceraudo E; Dodig-Crnković T; Uhle'n M; Svenningsson P; Schwenk JM; Sakmar TP
bioRxiv; 2023 Nov; ():. PubMed ID: 38045268
[TBL] [Abstract][Full Text] [Related]
17. Regulation of RAMP expression in diseases.
Jacob A; Wu R; Wang P
Adv Exp Med Biol; 2012; 744():87-103. PubMed ID: 22434110
[TBL] [Abstract][Full Text] [Related]
18. Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment.
Tilakaratne N; Christopoulos G; Zumpe ET; Foord SM; Sexton PM
J Pharmacol Exp Ther; 2000 Jul; 294(1):61-72. PubMed ID: 10871296
[TBL] [Abstract][Full Text] [Related]
19. Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat.
Oliver KR; Kane SA; Salvatore CA; Mallee JJ; Kinsey AM; Koblan KS; Keyvan-Fouladi N; Heavens RP; Wainwright A; Jacobson M; Dickerson IM; Hill RG
Eur J Neurosci; 2001 Aug; 14(4):618-28. PubMed ID: 11556887
[TBL] [Abstract][Full Text] [Related]
20. Receptor activity-modifying proteins; multifunctional G protein-coupled receptor accessory proteins.
Hay DL; Walker CS; Gingell JJ; Ladds G; Reynolds CA; Poyner DR
Biochem Soc Trans; 2016 Apr; 44(2):568-73. PubMed ID: 27068971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
